Literature DB >> 426181

A longitudinal study of tryptophan involvement in hepatic coma.

D G Hutson, J Ono, R S Dombro, J U Levi, A Livingstone, R Zeppa.   

Abstract

Previous cross-sectional studies have demonstrated that hepatic coma is associated with abnormally high levels of plasma free tryptophan. Establishment of a more definitive relationship between this biochemical abnormality and hepatic coma requires an evaluation of biochemical changes in individual patients as they undergo alterations in the function of their central nervous systems. The present report is an evaluation of tryptophan and substances believed to influence its entry into the brain in six patients whose clinical status progressed from hepatic coma to complete recovery. Consistent significant decreases in plasma free tryptophan and free fatty acids were demonsrated to occur as the patients recovered. No consistent changes, however, were found in the plasma levels of the amino acids which have been reported to compete with tryptophan for transport across the blood-brain barrier, except for leucine which was significantly decreased in all six patients upon recovery from coma. Assay of lumbar cerebrospinal fluid for both tryptophan and the serotonin metabolite, 5-hydroxyindoleacetic acid (5-HIAA), showed no consistent changes as the patients recovered from hepatic coma.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 426181     DOI: 10.1016/0002-9610(79)90153-3

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  6 in total

1.  The turnover of brain monoamines after total hepatectomy in rats infused with branched chain amino acids.

Authors:  M Bugge; F Bengtsson; A Nobin; B Jeppsson; P Herlin
Journal:  World J Surg       Date:  1987-12       Impact factor: 3.352

2.  Plasma and cerebrospinal fluid amino acid patterns in hepatic encephalopathy.

Authors:  A Cascino; C Cangiano; F Fiaccadori; F Ghinelli; M Merli; G Pelosi; O Riggio; F Rossi Fanelli; D Sacchini; M Stortoni; L Capocaccia
Journal:  Dig Dis Sci       Date:  1982-09       Impact factor: 3.199

3.  Raised plasma concentrations of 3-methoxy-4-hydroxyphenylethyleneglycol in cirrhotic patients with or without hepatic encephalopathy.

Authors:  H Echizen; A Minegishi; S Hayashi; N Umeda; T Oda; T Ishizaki
Journal:  Gut       Date:  1989-05       Impact factor: 23.059

Review 4.  Serotonin brain circuits with a focus on hepatic encephalopathy.

Authors:  Violina Lozeva-Thomas
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

5.  Branched-chain amino acids vs lactulose in the treatment of hepatic coma: a controlled study.

Authors:  F Rossi-Fanelli; O Riggio; C Cangiano; A Cascino; D De Conciliis; M Merli; M Stortoni; G Giunchi
Journal:  Dig Dis Sci       Date:  1982-10       Impact factor: 3.199

6.  CNS tryptamine metabolism in hepatic coma.

Authors:  S N Young; S Lal
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.